515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
Titel:
515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
Auteur:
Evangelista, M. Wang, E.W. Liu, L.F. Levin, B. Gleason, C.E. Odeh, R. Hamkins-indik, F. Cremin, P. Molina, C. Odena, A. Garcia, P.D. Serra, V. Cox, M.C. Earp, D.J.